BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

Yasmeen Rauf; Xuefei Jia; Justin Lathia; David Peereboom; Manmeet Ahluwalia

doi:10.1093/NEUONC/NOAA215.029

BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

Yasmeen Rauf, Xuefei Jia, Justin Lathia, David Peereboom, Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/NEUONC/NOAA215.029
State	Published - Nov 9 2020
Event	Neuro-oncology - Duration: Nov 9 2020 → …

Conference

Conference	Neuro-oncology
Period	11/9/20 → …

Disciplines

Oncology

Access to Document

10.1093/NEUONC/NOAA215.029License: Unspecified

Cite this

@conference{1afab59ba34745d883442d07062e615f,

title = "BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS",

author = "Yasmeen Rauf and Xuefei Jia and Justin Lathia and David Peereboom and Manmeet Ahluwalia",

note = "Abstract. Altered cellular growth and suppression of anti-tumor immune response collectively drive progression and therapeutic resistance of high-grade gliomas; Neuro-oncology ; Conference date: 09-11-2020",

year = "2020",

month = nov,

day = "9",

doi = "10.1093/NEUONC/NOAA215.029",

language = "American English",

}

TY - CONF

T1 - BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

AU - Rauf, Yasmeen

AU - Jia, Xuefei

AU - Lathia, Justin

AU - Peereboom, David

AU - Ahluwalia, Manmeet

N1 - Abstract. Altered cellular growth and suppression of anti-tumor immune response collectively drive progression and therapeutic resistance of high-grade gliomas

PY - 2020/11/9

Y1 - 2020/11/9

UR - https://academic.oup.com/neuro-oncology/article/22/Supplement_2/ii8/5960530

U2 - 10.1093/NEUONC/NOAA215.029

DO - 10.1093/NEUONC/NOAA215.029

M3 - Presentation

T2 - Neuro-oncology

Y2 - 9 November 2020

ER -

BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

Conference

Disciplines

Access to Document

Other files and links

Cite this